Lucid Diagnostics
Alena Androsenka is an accomplished professional with extensive experience in revenue cycle management and billing operations. Currently serving as Sr. Director of Revenue Cycle Management at Lucid Diagnostics and an Independent Consultant at Andros Strategic Consulting, Alena previously held senior roles at BostonGene and Foundation Medicine, overseeing billing and market access operations. Alena's earlier career includes positions at Brigham and Women's Hospital, Mission Health Systems, Gentle Dental, and Melvin Pharmacy. Alena holds a Bachelor of Science in Business Management from Mars Hill University and an Associate Degree in Education with a focus on Foreign Languages from Gomel'ski Dzjaržauny Universitet imja Franciska Skarany.
This person is not in any teams
This person is not in any offices
Lucid Diagnostics
1 followers
Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc (Nasdaq: PAVM) that has breakthrough devices, EsoCheck and EsoGuard, for esophageal cell collection and diagnosis of Barrett's Esophagus.